-
Mashup Score: 1553CERN working with WHO to improve understanding of COVID-19 airborne transmission risk in indoor spaces - 2 month(s) ago
As the response to the pandemic evolves and people step back into the office, it is necessary to monitor continuously the risk of disease transmission and be prepared to make quick, evidence-based decisions to ensure that everyone can work safely. CERN has developed the COVID Airborne Risk Assessment tool (CARA) to help personnel return to work safely by assessing the risk of COVID-19 infection in enclosed spaces like offices or meeting rooms. In accordance with CERN’s knowledge-transfer strategy, CERN has made the CARA software open-source, and the tool is freely available to all on GitLab. The tool has attracted the attention of many international organisations, including the World Health Organization (WHO) and the United Nations Office at Geneva (UNOG). In June 2021, CERN shared its approach to risk assessment of occupational hazards, presenting CARA to WHO’s COVID Expert Panel. As a result, WHO has now invited CERN to become a member of a multidisciplinary working group of interna
Source: home.cernCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 749Immune escape of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1 after vaccination, infection and hybrid immunity - 3 month(s) ago
Since their emergence in late 2021, SARS-CoV-2 Omicron replaced earlier variants of concern and marked a new phase in the SARS-CoV-2 pandemic. Until the end of 2023, Omicron lineages continue to circulate and continue to evolve, with new lineages causing infection waves throughout 2022 and 2023. In the population, this leads to a complex immunological exposure background, characterized by immunity derived through vaccination, in the 5th year of the pandemic in the majority of individuals followed by at least one or even multiple infections or only natural infection in individuals that did not receive a vaccine. In this study, we use eight authentic SARS-CoV-2 isolates (ancestral lineage B.1 and the seven Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1) in a live virus neutralization assay to study immune escape in 97 human sera or plasma of different immunological backgrounds (vaccination, hybrid immunity due to one or two natural infections and natural infection
Source: www.biorxiv.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2
A third dose of a COVID-19 mRNA vaccine based on the wild-type spike glycoprotein significantly boosts neutralising antibody titres in patients with IBD. However, responses are lower against the Omicron variant BA.4/5, particularly in patients taking anti-TNF and JAK-inhibitor therapy. Breakthrough infections are associated with lower neutralising antibodies and immunosuppressed patients with IBD may receive additional benefit from bivalent vaccine boosters which target Omicron variants.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2208
Grob geschätzt ist oder war gerade jeder Zehnte im Land krank. Die vielen Fehltage verursachen hohe Kosten, wie das Kieler IfW-Institut ausgerechnet hat, und volkswirtschaftlich einen enormen Schaden.
Source: www.spiegel.deCategories: General Medicine News, Infectious DiseaseTweet
For the last few years, @WHO and @CERN have been developing a risk assessment tool to estimate indoor airborne transmission of #SARSCoV2 to better advise on risk mitigation measures for #COVID19.🧵 https://t.co/opyn5N6Sin